Live Nasdaq Composite: Market Sentiment Sours as Investors Question Big Tech Earnings and Oil Pulls Back From $100

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1518 Articles

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Douglas A. McIntyre | Jul 11, 2018 at 5:07 AM EDT

6 Most Important Things in Business Today

JetBlue orders planes from Airbus, Pfizer to defer some drug price increases, Toyota launches car-sharing service in Hawaii, and other…

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 25, 2018 at 9:00 AM EDT

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Chris Lange | Jun 6, 2018 at 1:35 PM EDT

Pfizer Drops $600 Million in Its Venture Capital Arm

Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a…

Lee Jackson | May 30, 2018 at 8:10 AM EDT

4 Dividend Stocks That Are Still Better Buys Than Bonds

These four stocks may not be as safe as U.S. Treasury debt, but they still would make great additions to…

Chris Lange | May 29, 2018 at 8:35 AM EDT

Meet Pfizer’s Newest FDA Designations

Pfizer announced early on Monday that it received a couple critical updates from the FDA related to its Xalkori (crizotinib).

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 19, 2018 at 8:25 AM EDT

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.

Paul Ausick | May 18, 2018 at 9:45 AM EDT

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received…

Paul Ausick | May 14, 2018 at 4:01 PM EDT

UnitedHealth, Walmart Buoy the Dow Monday

UnitedHealth, Walmart, Pfizer, and DowDuPont did their best to pin a small gain on the Dow Monday.

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | May 1, 2018 at 4:01 PM EDT

Pfizer, Merck Sink the Dow Tuesday

Pfizer, Merck, McDonald's, and Coca-Cola were the big losers Tuesday among the 30 Dow stocks.

Chris Lange | May 1, 2018 at 9:55 AM EDT

How Much Pfizer Earnings Depend on a Few Brands

Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.

1 … 36 37 38 39 40 … 102

Pfizer : PFE

All Pfizer Articles

Where Did Major Pharma Short Sellers Go?

6 Most Important Things in Business Today

Short Sellers Hike Bets in Major Pharma Stocks

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Major Pharmaceuticals Scare Off Short Sellers

Pfizer Drops $600 Million in Its Venture Capital Arm

4 Dividend Stocks That Are Still Better Buys Than Bonds

Meet Pfizer’s Newest FDA Designations

Major Pharma Short Sellers Grow More Selective

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

UnitedHealth, Walmart Buoy the Dow Monday

Short Sellers Run for Cover From Major Pharma

Pfizer, Merck Sink the Dow Tuesday

How Much Pfizer Earnings Depend on a Few Brands

Live Nasdaq Composite: Market Sentiment Sours as Investors Question Big Tech Earnings and Oil Pulls Back From $100

Tesla Sinks 18% in a Month as Lucid Climbs 21%, Rivian Gains 9%: SpaceX Anxiety or Cracks Under the Hood?

After Comparing Every Weekly Income ETF These 3 Pay You Every Single Friday

The Anti-Nvidia ETF: Why Contrarians Are Buying the Stocks Nobody Wants

She Chose Retirement Over the Next Tech Overhaul. It Unlocked a Hidden Social Security Window.

The RMD Trap That Quietly Costs Retirees Thousands in Medicare Premiums and How to Avoid It

Tesla Sinks 18% in a Month as Lucid Climbs 21%, Rivian Gains 9%: SpaceX Anxiety or Cracks Under the Hood?

After Comparing Every Weekly Income ETF These 3 Pay You Every Single Friday

Pfizer : PFE

All Pfizer Articles

Where Did Major Pharma Short Sellers Go?

6 Most Important Things in Business Today

Short Sellers Hike Bets in Major Pharma Stocks

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Major Pharmaceuticals Scare Off Short Sellers

Pfizer Drops $600 Million in Its Venture Capital Arm

4 Dividend Stocks That Are Still Better Buys Than Bonds

Meet Pfizer’s Newest FDA Designations

Major Pharma Short Sellers Grow More Selective

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

UnitedHealth, Walmart Buoy the Dow Monday

Short Sellers Run for Cover From Major Pharma

Pfizer, Merck Sink the Dow Tuesday

How Much Pfizer Earnings Depend on a Few Brands

Live Nasdaq Composite: Market Sentiment Sours as Investors Question Big Tech Earnings and Oil Pulls Back From $100

Tesla Sinks 18% in a Month as Lucid Climbs 21%, Rivian Gains 9%: SpaceX Anxiety or Cracks Under the Hood?

After Comparing Every Weekly Income ETF These 3 Pay You Every Single Friday

The Anti-Nvidia ETF: Why Contrarians Are Buying the Stocks Nobody Wants

Featured Reads

She Chose Retirement Over the Next Tech Overhaul. It Unlocked a Hidden Social Security Window.

The RMD Trap That Quietly Costs Retirees Thousands in Medicare Premiums and How to Avoid It